Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Grupo Espanol De Tumores Neuroendocrinos

Clinical trials sponsored by Grupo Espanol De Tumores Neuroendocrinos, explained in plain language.

Trials to join now! 3 Not yet finished but already full! 1 Completed 1 Terminated 1

Spanish doctors review rare cancer Drug's Real-World impact

Knowledge-focused Completed

This study looked back at medical records to learn how 20 Spanish cancer patients with a specific, rare genetic change (NTRK fusion) responded to the drug larotrectinib. The patients received the drug through a special access program before it was commercially available. The goal…

Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Knowledge-focused

Last updated Mar 18, 2026 14:40 UTC